Researchers compared the QRISK3 and the adjusted Global AntiPhospholipid Syndrome Score in patients with systemic lupus erythematosus to assess their risk of developing cardiovascular disease.
Researchers investigated the impact of time to remission, number of flares, and time on immunosuppressives after remission on estimated glomerular filtration rate in patients with lupus nephritis.
Researchers developed a consensus-based standardized corticosteroid dosing regimen for patients with childhood-onset systemic lupus erythematosus with lupus nephritis.
Marcus Säemann, MD, talks about the role of SGLT-2 inhibitors and their strong nephroprotective potential that may benefit patients with ANCA-associated vasculitis and lupus nephritis.
Researchers compared cardiovascular risk among patients with gout who received treatment with allopurinol vs benzbromarone.
In an interview, Brian LaMoreaux, MD, MS, discusses the need for evidence-based strategies to improve outcomes for patients hospitalized with gout.
Robert T. Keenan, MD, discusses the role of co-treatment with immunomodulators and pegloticase in patients with uncontrolled gout.
Researchers evaluated the effect of mycophenolate mofetil on the efficacy of pegloticase in patients with refractory gout.
Study authors aimed to develop a new ultrasound definition and a semi-quantitative ultrasound scoring system for gout lesions.
